About
Dr. Brad Walsh brings over 30 years of experience in the biotechnology business and has enjoyed a successful career commercializing immunoassay kits, proteomics technologies and consumables, and bioinformatics software. His products are being sold and supplied by major US corporations, such as Bio-Rad Laboratories. He is the founder of Minomic and in the early 2000’s started the predecessor of Minomic International Ltd as a private company, raising over $5M in equity investment and non-dilutive funding. In the mid-90 he was the inaugural General Manager of an Australian National Research Facility, which was the world leader in the groundbreaking new field of proteomics.
Position in the VCSift Database
- • 3,360 investors hold the CEO role in VCSift. Brad Walsh is one of them.
- • 2 investors are based in Port Macquarie, New South Wales, Australia.
Data sourced from 410,343 investor profiles. Updated July 2026.
Investment Focus
- Location
- Port Macquarie, Australia
Contact Information
Find more investors like Brad
Search Investors